Merger Notification - Announcement according to § 10 Cartel Act
Blackstone Life Sciences Advisors LLC; GEMoab GmbH; Intellia Therapeutics Inc
BWB/Z-5495
On 28.06.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Adira Therapeutics, Inc., a newly incorporated holding company in which each of Blackstone Life Sciences Advisors L.L.C. or its affiliates, Intellia Therapeutics Inc., and Cellex Cell Professionals GmbH will hold 25% or more shares, intends to acquire all shares in and sole control over GEMoab GmbH.
Economic sector: Manufacture of pharmaceutical preparations
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 26.07.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 27.07.2021 .